XSHE
002407
Market cap5.34bUSD
Oct 09, Last price
31.89CNY
1D
6.12%
1Q
-22.41%
Jan 2017
63.60%
IPO
464.18%
Name
Do-Fluoride New Materials Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Do-Fluoride New Materials Co., Ltd., previously named Do-Fluoride Chemicals Co., Ltd., is an enterprise primarily focused on the research, development, manufacturing, and international sale of inorganic fluorides, electronic chemicals, and both components and complete systems for lithium-ion batteries. Their extensive product line includes various smelting-grade fluorides such as anhydrous aluminum fluoride, hydrogen fluoride, synthetic cryolite, and granulated synthetic cryolite. They also supply sodium fluoride, fluosilicate, potassium fluoaluminate, potassium borofluoride, and anhydrous calcium chloride. For the electronics sector, the company provides high-purity chemicals like lithium hexafluorophosphate and hydrofluoric acid, along with standard samples of cryolite and aluminum fluoride. Additionally, Do-Fluoride ventures into the electric vehicle market and provides financial loan services. The company was founded in 1999 and operates from its headquarters in Jiaozuo, located in the People's Republic of China.
Key people
Lijing Cheng
Chief Financial Officer, Director · since 2025
Yongfeng Zhao
Deputy General Manager · since 2020
Chao Peng
Secretary of the Board · since 2023
Shijiang Li
Director · since 2025
Yunfeng Li
Chairman of the Board, General Manager · since 2025
Huachun Yang
Director · since 2023
Xiaoping Zhou
Deputy General Manager, Staff Elected Director · since 2025
Xiaolan Chen
Independent Director · since 2023
Xiangbing Xie
Independent Director · since 2025
Lijun Ye
Independent Director · since 2023
Qingjiao Yu
Independent Director · since 2025
Headquarters & legal address
焦作市中站区焦克路
焦作市, HA 100000
CN
焦作市, HA 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||